208 related articles for article (PubMed ID: 36261102)
1. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
Kumar A; Ravi R; Sivakumar RK; Chidambaram V; Majella MG; Sinha S; Adamo L; Lau ES; Al'Aref SJ; Asnani A; Sharma G; Mehta JL
Curr Probl Cardiol; 2023 Feb; 48(2):101461. PubMed ID: 36261102
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S
Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781
[TBL] [Abstract][Full Text] [Related]
3. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
[TBL] [Abstract][Full Text] [Related]
6. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
Mujkanovic J; Qayyum AA
Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
[TBL] [Abstract][Full Text] [Related]
8. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
[TBL] [Abstract][Full Text] [Related]
12. A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis.
Hoevelmann J; Engel ME; Muller E; Hohlfeld A; Böhm M; Sliwa K; Viljoen C
Eur J Heart Fail; 2022 Sep; 24(9):1719-1736. PubMed ID: 35778990
[TBL] [Abstract][Full Text] [Related]
13. [Peripartum Cardiomyopathy].
Pfeffer TJ; König T; Berliner D; Bauersachs J
Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K
Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866
[TBL] [Abstract][Full Text] [Related]
15. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.
Hilfiker-Kleiner D; Haghikia A; Masuko D; Nonhoff J; Held D; Libhaber E; Petrie MC; Walker NL; Podewski E; Berliner D; Bauersachs J; Sliwa K
Eur J Heart Fail; 2017 Dec; 19(12):1723-1728. PubMed ID: 28345302
[TBL] [Abstract][Full Text] [Related]
16. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J
Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513
[TBL] [Abstract][Full Text] [Related]
17. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
[TBL] [Abstract][Full Text] [Related]
18. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
[TBL] [Abstract][Full Text] [Related]
19. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
Farhan HA; Yaseen IF
ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy.
Badianyama M; Das PK; Gaddameedi SR; Saukhla S; Nagammagari T; Bandari V; Mohammed L
Cureus; 2021 Sep; 13(9):e18248. PubMed ID: 34603902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
